These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32866590)

  • 1. Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration.
    Wang J; Ni Q; Wang Y; Zhang Y; He H; Gao D; Ma X; Liang XJ
    J Control Release; 2021 Mar; 331():282-295. PubMed ID: 32866590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a tool to overcome macromolecules delivery issues.
    Tundisi LL; Ataide JA; Costa JSR; Coêlho DF; Liszbinski RB; Lopes AM; Oliveira-Nascimento L; de Jesus MB; Jozala AF; Ehrhardt C; Mazzola PG
    Colloids Surf B Biointerfaces; 2023 Feb; 222():113043. PubMed ID: 36455361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers.
    Ouyang X; Liu Y; Zheng K; Pang Z; Peng S
    Asian J Pharm Sci; 2024 Feb; 19(1):100883. PubMed ID: 38357524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure.
    Lin C; Gao H; Ouyang L
    J Control Release; 2021 Sep; 337():494-504. PubMed ID: 34358590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Drug Delivery: Historical perspective for the next generation.
    Yun YH; Lee BK; Park K
    J Control Release; 2015 Dec; 219():2-7. PubMed ID: 26456749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery and nanoparticles:applications and hazards.
    De Jong WH; Borm PJ
    Int J Nanomedicine; 2008; 3(2):133-49. PubMed ID: 18686775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine and Addictive Disorders: A New Approach With Cannabinoids.
    Giménez VMM; Menéndez SG; Manucha W
    Curr Pharm Des; 2022; 28(34):2795-2799. PubMed ID: 36082864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-nanoscale drugs and delivery systems.
    Singh S
    J Nanosci Nanotechnol; 2010 Dec; 10(12):7906-18. PubMed ID: 21121278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.
    Curtis C; Zhang M; Liao R; Wood T; Nance E
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27562224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in kidney-targeted drug delivery systems.
    Chen Z; Peng H; Zhang C
    Int J Pharm; 2020 Sep; 587():119679. PubMed ID: 32717283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution considerations associated with nano drug delivery systems.
    Gupta R; Chen Y; Xie H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1732. PubMed ID: 34132050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second world conference on nanomedicine and drug delivery.
    Ninan N; Thomas S; George A; Sebastian M
    Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevant Physicochemical Descriptors of "Soft Nanomedicines" to Bypass Biological Barriers.
    Nino-Pariente A; Nebot VJ; Vicent MJ
    Curr Pharm Des; 2016; 22(9):1274-91. PubMed ID: 26675217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.